| Name | Title | Contact Details |
|---|
MedAvante Inccvc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MedAvante Inccvc is based in Trenton, NJ. You can find more information on MedAvante Inccvc at www.medavante.net
As everyday life becomes more challenging, a little help can go a long way. Home Helpers provides one-on-one in home care services to seniors and other individuals in need of continuing and recuperative home care. From a few hours a week to 24/7 home care, we`re there when and where you need us to help make life easier!
IDLife stands for “Individually Designed Life.” You really can have the best health you’ve ever experienced, the income you’ve always desired and the lifestyle you deserve. Healthy Simplified.
We`re on a mission to make life better for patients taking part in clinical trials around the world, and their caregivers. Our solutions focus on the four key elements of a successful clinical trial: recruitment, engagement, retention and trial outcomes. Combining our in-house technology platforms with 24/7 truly personalised patient care, we focus on creating remarkable patient experiences at every stage of the clinical journey. Remarkable means going above and beyond to support patients in a way that works best for them and their lives. Whether that`s facilitating clinical trial participation in their own homes, supporting them to travel safely to and from study sites, or using technology to manage everything from expense reimbursement to telehealth, we work with our partners to support the protocol design that meets their patient`s needs. Understanding the complexities of the patient journey is paramount to advancing medicine, and exploring digital technology that enables better trial outcomes has never been more important. This all starts with putting patients first in clinical research. When you partner with us, your patients receive a truly remarkable service and your trial outcomes are better.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.